Physicians are increasingly seeking PE partnerships to navigate a complex modern landscape:
: While primary care was the early focus, firms are now aggressively targeting high-margin specialties including dermatology, ophthalmology, gastroenterology, and orthopedics.
: PE provides the funds needed to upgrade electronic medical record (EMR) systems and invest in advanced diagnostic tools. private equity firms buying medical practices
This feature explores the evolving landscape of private equity (PE) acquisitions in the medical sector as of 2026.
: Declining reimbursements and the high cost of shifting to Value-Based Care (VBC) models make the financial backing of a large firm attractive. 3. The Impact: Cost, Quality, and Autonomy : Declining reimbursements and the high cost of
After a period of stabilization, healthcare private equity deal value reached an estimated , surpassing previous highs. This momentum has carried into 2026, driven by a massive "dry powder" stockpile and a pivot toward technology-enabled assets like AI-based telehealth and revenue cycle management.
: Firms centralize "back-office" functions (billing, HR, payroll), allowing doctors to focus theoretically on clinical care. This momentum has carried into 2026, driven by
The shift from physician-owned to corporate-owned care has drawn intense scrutiny due to several documented trends:
